About BirchBioMed
BirchBioMed is a clinical-stage biomedical company focused on the commercialization, clinical evaluation and development of proprietary anti-scarring drugs, autoimmune therapeutics/ therapies and novel strategies for transplantation.
New York
866.350.1993
Toronto
905.833.0826
Vancouver
778.989.5104